PTC Therapeutics director Michael Schmertzler disposes of USD 1.82 million in common shares

PUBT · 1d ago
PTC Therapeutics director Michael Schmertzler disposes of USD 1.82 million in common shares
  • PTC Therapeutics director Michael Schmertzler reported sales of 25,000 common shares on Aug. 26-27.
  • Shares sold at weighted average prices between USD 71.55 and USD 73.18.
  • Indirect stake fell to 1,336,594 shares following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PTC Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001288952-26-000006), on August 28, 2026, and is solely responsible for the information contained therein.